Table 3.
Comparisons of blood biomarkers of study subjects.
| Group | FBG (mmol/L) |
2hPG (mmol/L) |
HbA1C (%) | FINS (mu/L) |
2hINS (mu/L) |
C-P (ng/mL) |
2hC-P (ng/mL) |
HOMA-IR |
|---|---|---|---|---|---|---|---|---|
| Normal control | 4.71 ± 1.2 | 5.72 ± 1.8 | 4.7 ± 0.4 | 13.7 ± 3.6 | 43.2 ± 7.63 | 1.46 ± 0.78 | 4.32 ± 1.30 | 2.91 ± 1.10 |
| Simple obesity | 4.96 ± 1.06 | 5.96 ± 1.23 | 5.1 ± 0.3 | 17.2 ± 1.7☆ | 40.1 ± 3.72 | 1.56 ± 0.62 | 4.30 ± 0.98 | 4.70 ± 1.24☆ |
| Type 2 diabetes | ||||||||
| Nonobese | 9.25 ± 3.12☆☆○○ | 12.56 ± 1.03☆☆○○ | 8.7 ± 1.2☆☆○○ | 23.6 ± 4.7☆☆ | 52.7 ± 4.6☆☆○○ | 3.03 ± 0.32☆○ | 7.98 ± 0.72☆☆○○ | 8.47 ± 3.7☆☆○○ |
| Obese | 9.65 ± 2.16☆☆○○ | 13.76 ± 2.53☆☆○○ | 8.9 ± 0.9☆☆○○ | 25.2 ± 8.7☆☆ | 49.3 ± 5.3☆☆○○ | 3.06 ± 0.43☆○ | 8.76 ± 0.69☆☆○○ | 11.3 ± 2.6☆☆○○∆ |
FBG: fasting plasma glucose; 2hPG: 2 h postchallenge plasma glucose; HbA1C: glycated hemoglobin A1C; FINS: fasting insulin; 2hINS: 2 h postprandial insulin; C-P: C-peptide; 2hC-P: 2 h postprandial C-peptide; HOMA-IR: Homeostasis Model Assessment Index of insulin resistance. Data are mean ± SD or median. ☆ P < 0.05, ☆☆ P < 0.01 versus normal control; ○ P < 0.05, ○○ P < 0.01 versus simple obese group; ∆ P < 0.05 versus nonobese diabetic group.